Search Share Prices
AZN Share Price - AstraZeneca sells rights to breast, prostate cancer drugs for US$181mln
The FTSE 100-listed firm already sold commercial rights in the US in 2017, while now the drugs have lost exclusive rights in most countries in Europe and Africa AstraZeneca PLC (LON:AZN) has agreed to ...
Flu Vaccine Market to Show Great Impact in Future by 2023
Get Sample Copy of this Report @https://www.bigmarketresearch.com/request-sample/3312721?utm_source=Geeta-IR By Top Market Players: CSL CSL, +0.08%, GSK GSK, +0.28%, Sanofi Pasteur (epa:SAN), Mylan ...
AstraZeneca Selects IQVIA OCE to Help Further its Digital Focus
IQVIA™ (NYSE: IQV) today announced that AstraZeneca (LON: AZN) has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform to further its digital agenda and establish its "Field ...
Flu Vaccine Market Study of Revenue Details, Threats in the Target Market and Forecast By 2023
Get Sample Copy of this Report @https://www.bigmarketresearch.com/request-sample/3312721?utm_source=Geeta-MRA By Top Market Players: CSL CSL, -0.76%, GSK GSK, +0.51%, Sanofi Pasteur (epa:SAN), Mylan ...
AstraZeneca (LON:AZN) PT Set at GBX 7,350 by Jefferies Financial Group
AstraZeneca (LON:AZN) received a GBX 7,350 ($96.69) price target from equities researchers at Jefferies Financial Group in a research report issued on Tuesday, Borsen Zeitung reports. The firm ...